Nurix Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nurix Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2024.
  • Nurix Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending November 30, 2024 was $28.1M, a 9.64% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $28.1M -$3M -9.64% Nov 30, 2024 10-K 2025-01-28
Q3 2024 $27.1M +$18.1M +200% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $28.8M +$18.9M +190% May 31, 2024 10-Q 2024-07-11
Q1 2024 $29.3M +$18.4M +168% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $31.1M +$18.8M +152% Nov 30, 2023 10-K 2025-01-28
Q3 2023 $9.03M -$4.82M -34.8% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $9.94M -$5.48M -35.5% May 31, 2023 10-Q 2023-07-13
Q1 2023 $10.9M -$4.96M -31.2% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $12.3M -$1.66M -11.9% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $13.8M Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $15.4M May 31, 2022 10-Q 2022-07-07
Q1 2022 $15.9M Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $14M +$662K +4.96% Nov 30, 2021 10-K 2023-02-09
Q4 2020 $13.3M Dec 1, 2020 10-Q 2022-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.